MAC Project, Monitoring of AntiCoagulant Therapies (MAC)

CompletedOBSERVATIONAL

Enrollment

2,000

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2024

Conditions

Anticoagulants and Bleeding Disorders

Interventions

DRUG

Anticoagulant drugs

Prescription of, or already on oral anticoagulant treatment.

Trial Locations (1)

Giuseppe Camporese, Padua

All Listed Sponsors

lead

Quovadis Associazione

OTHER

NCT04329390 - MAC Project, Monitoring of AntiCoagulant Therapies (MAC) | Biotech Hunter | Biotech Hunter